AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 67 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,414 | -65.3% | 121,416 | -72.2% | 0.00% | -100.0% |
| Q2 2023 | $399,186 | +4557.4% | 436,269 | +2836.8% | 0.00% | – |
| Q4 2022 | $8,571 | -87.0% | 14,855 | -92.9% | 0.00% | – |
| Q3 2022 | $66,000 | -68.7% | 209,755 | -64.9% | 0.00% | -100.0% |
| Q2 2022 | $211,000 | +33.5% | 598,379 | +1339.7% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | -46.3% | 41,564 | +92.3% | 0.00% | -50.0% |
| Q2 2020 | $294,000 | – | 21,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |